Page 5 - Precision Timed Release News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Cingulate Inc to Present at the LD Micro Main Event XVI - Cingulate (NASDAQ:CING), Cingulate (NASDAQ:CINGW)

KANSAS CITY, Kan., Sept. 21, 2023 (GLOBE NEWSWIRE) Cingulate Inc. (NASDAQ:CING), a biopharmaceutical company utilizing its proprietary Precision Timed Release™ (PTR™) drug delivery platform technology

Kansas cityUnited statesLos angelesChris lahijiThomas daltonShanej schafferMatt krepsHotel in los angelesDarrow associatesCingulate incPrecision timed releaseMain eventLuxe sunset boulevardSweet sixteenLuxe sunset boulevard hotelPublic relations

Cingulate Announces Closing of $4 0 Million Public Offering

Cingulate Announces Closing of $4 0 Million Public Offering
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Kansas cityUnited statesNew yorkThomas daltonviceHc wainwright coExchange commissionSecurities exchangeCingulate incMelysa weibleelixir health public relationsMatt krepsdarrow associatesPrecision timed releaseLooking statementsSecurities actSecurities exchange actAnnual reportDaltonvice president

Cingulate Inc (CING) Announces Detailed Trial Results from Phase 3 Adult Efficacy and Safety Trial of CTx-1301

Cingulate Inc (CING) Announces Detailed Trial Results from Phase 3 Adult Efficacy and Safety Trial of CTx-1301
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesThomase brownThomas daltonviceRaul silvaAnn childressDrug administrationAmerican psychiatric association publishingPsych congressBehavior medicine incPsych congress first annual posterExchange commissionSecurities exchangeMedia relationsmelyssa weibleelixir health public relationsCingulate incMatt krepsdarrow associatesPrecision timed release

Cingulate Announces Pricing of $4 0 Million Public Offering

KANSAS CITY, Kan., Sept. 11, 2023 (GLOBE NEWSWIRE) Cingulate Inc. (NASDAQ: CING) (“Cingulate,” the “Company,” “we,” “our” or “us”), a biopharmaceutical company utilizing its proprietary Precision Timed Release™ (PTR™)

United statesKansas cityNew yorkMelysa weibleMatt krepsThomas daltonElixir health public relationsExchange commissionCingulate incSecurities exchangeDarrow associatesHc wainwright coPrecision timed releaseLooking statementsSecurities actSecurities exchange act

Cingulate Inc (CING) Prices 6 93M Share Offering at $0 5776/sh

Cingulate Inc (CING) Prices 6 93M Share Offering at $0 5776/sh
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

New yorkUnited statesHc wainwright coCingulate incExchange commissionPrecision timed release